Micropulse Laser Trabeculoplasty | 合法醫療器材資訊網

Anewoptioninglaucomatreatmentismicropulselasertrabeculoplasty...MLToffersphysiciansthepotentialtodojustthatbyloweringIOPwithfewsideeffects.

The clinical management of glaucoma is evolving, thanks to changes in population demographics, a growing understanding of the disease, and, most importantly, advances in both pharmaceutical and laser technology. Medicare claims data show that the number of trabeculectomies performed has decreased by 44% in the decade since latanoprost was introduced. Better medical therapy has meant fewer filtering surgeries, despite an aging population. Since 2001, the year that selective laser trabeculoplasty (SLT) was approved, physicians use of the laser trabeculoplasty code has more than doubled.1

A new option in glaucoma treatment is micropulse laser trabeculoplasty (MLT). The procedure is performed with the Iridex IQ810 810-nm laser (Iridex Corporation, Mountain View, CA), a multifunctional laser system. The platform has many other applications for ophthalmology, including transscleral cyclophotocoagulation (see ...